Patent Assignment
Reel/Frame 016075/0555
Security Interest
Recorded: 2005-05-31
Pages: 4
Assignor
CENES PHARMACEUTICALS, INC.
Executed: 2004-02-05
Assignee
ACORDA THERAPEUTICS, INC.
15 SKYLINE DRIVE, HAWTHORNE, NEW YORK, 10532
Covered Property
(1)
Methods of Increasing Myotube Formation or Survival, or Muscle Cell Mitogenesis, Differentiation or Survival Using Neuregulin Ggf Iii
Patent:
7,115,554 →
Application:
08/209,204 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 25, 1994
From: SKLAR, ROBERT; MARCHIONNI, MARK; GWYNNE, DAVID I.
To: CAMBRIDGE NEUROSCIENCE
Reel/Frame 007291/0979 →
Change of Name
May 21, 2001
From: CAMBRIDGE NEUROSCIENCE, INC.
To: CENES PHARMACEUTICALS, INC.
Reel/Frame 011812/0784 →
Assignment of Assignor's Interest
Sep 27, 2004
From: CENES PHARMACEUTICALS, INC.
To: ACORDA THERAPEUTIC, INC.
Reel/Frame 015823/0604 →
Security Interest
Jun 10, 2016
From: ACORDA THERAPEUTICS, INC.; CIVITAS THERAPEUTICS, INC.; NEURONEX, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 038950/0436 →
Release of Security Interest
May 31, 2017
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NEURONEX, INC.; CIVITAS THERAPEUTICS, INC.; ACORDA THERAPEUTICS, INC.
Reel/Frame 042643/0878 →